QT
ANIK icon

Quantamental Technologies’s Anika Therapeutics ANIK Stock Holding History

Quantamental Technologies’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,115
Closed -$116K – 470
2019
Q3 		$116K Sell
2,115
-96
-4% -$4.93K 0.04% 677
2019
Q2 		$90K Sell
2,211
-73
-3% -$2.66K 0.03% 710
2019
Q1 		$69K Buy
+2,284
New +$78.2K 0.03% 739

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Quantamental Technologies's ANIK Position: Q4 2019 in Review

Quantamental Technologies sold out of Anika Therapeutics (ANIK) in Q4 2019, closing a stake of 2,115 shares — an estimated $116K sold.

Quantamental Technologies first reported a position in ANIK in Q1 2019 and held it in 3 quarters. The position peaked at $116K in Q3 2019. 191 funds tracked by Wall St. Rank hold ANIK as of Q4 2019.

  • Quantamental Technologies reported no remaining Anika Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Quantamental Technologies sold 2,115 Anika Therapeutics shares in Q4 2019, an estimated $116K.
  • Quantamental Technologies first reported a position in Anika Therapeutics in Q1 2019 and held it in 3 quarters.
  • Quantamental Technologies's Anika Therapeutics position peaked at $116K in Q3 2019.
  • 191 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2019.

Based on Quantamental Technologies's 13F filing for Q4 2019, filed 14 Feb 2020.